Contact
Please use this form to send email to PR contact of this press release:
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
TO:
Please use this form to send email to PR contact of this press release:
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
TO: